Dr. Joel Ross, the New Jersey geriatrician and clinical researcher behind trials of earlier Alzheimer''s therapies, on what anti-amyloid drugs actually change in everyday care.

Mitral regurgitation is one of the most common heart valve conditions worldwide. For much of modern medicine, patients with ...

For a long time the extent of sobriety tech was a simple counter that told you how many days you''d gone without a drink.

Atrial fibrillation raises the lifetime risk of stroke roughly fivefold, and for decades, physicians have relied on ...

Wearable technology has evolved from basic step counters to sophisticated devices capable of monitoring various aspects of personal health in real-time. As technology advances, these devices are ...

Peripheral Vascular Disease (PVD) limits blood flow to the limbs, most often affecting the legs and impacting daily mobility. Early detection and intervention make a significant difference in ...

Dr. James C. Wittig, one of the world's top orthopedic oncologists, led a team of residents and innovators in 2024 to successfully implement a surgical solution for an exceedingly rare orthopedic ...

For medical device manufacturers targeting the European Union market, compliance with the Medical Device Regulation (MDR) is essential, and many devices require formal conformity assessment before ...

The conversation around longevity is shifting. For decades, the goal was simple: live longer. But as medicine advances and populations age, a more nuanced question has emerged: how well can we live ...

MAKO Medical Laboratories, led by founder Chad Price, has steadily climbed the ranks of Business North Carolina's Top 125 Private Companies, recently securing the 55th position. While the company's ...

The healthcare industry is experiencing a significant shift with the integration of digital innovations in cold chain management. These advancements are crucial for maintaining the integrity of ...

Myra Ahmad keeps returning to a quiet failure in how patients are looked after. The information that should guide their care is scattered where no one can use it. "Most providers are getting labs from ...